Can Antitumor Immunity Help to Explain “Oncogene Addiction”?
- 16 November 2010
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 18 (5) , 403-405
- https://doi.org/10.1016/j.ccr.2010.11.002
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene InactivationPublished by Elsevier ,2010
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- Adoptive immunotherapy of cancer using CD4+ T cellsCurrent Opinion in Immunology, 2009
- Oncogene Addiction versus Oncogene Amnesia: Perhaps More than Just a Bad Habit?Cancer Research, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- The Concept of Synthetic Lethality in the Context of Anticancer TherapyNature Reviews Cancer, 2005
- Oct-3/4 is a dose-dependent oncogenic fate determinantCancer Cell, 2003
- Reversible Tumorigenesis by MYC in Hematopoietic LineagesMolecular Cell, 1999